We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+11.51%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$345M
AUM Growth
+$902K
Cap. Flow
-$15.5M
Cap. Flow %
-4.49%
Top 10 Hldgs %
50.71%
Holding
65
New
21
Increased
9
Reduced
14
Closed
16

Top Buys

Rank Stock Value
1
MTD icon
Mettler-Toledo International
MTD
+$4.19M
2
NVO
Novo Nordisk
NVO
+$3.84M
3
BDX icon
Becton Dickinson
BDX
+$3.81M
4
AZN icon
AstraZeneca
AZN
+$3.51M
5
BIIB icon
Biogen
BIIB
+$3.27M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$4.64M
2
CI icon
Cigna
CI
+$4.04M
3
ZBH icon
Zimmer Biomet
ZBH
+$3.94M
4
WST icon
West Pharmaceutical
WST
+$3.94M
5
DGX icon
Quest Diagnostics
DGX
+$3.81M

Sector Composition

Rank Sector Weight
1 Healthcare 51.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBI icon
1
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$27.4M 7.96%
225,000
-25,000
-10% -$2.87M
LLY icon
2
Eli Lilly
LLY
$1.06T
$7.52M 2.18%
7,000
-3,000
-30% -$2.87M
THC icon
3
Tenet Healthcare
THC
$21.1B
$7.45M 2.16%
37,500
+2,500
+7% +$505K
MCK icon
4
McKesson
MCK
$101B
$7.38M 2.14%
9,000
+2,000
+29% +$1.63M
HCA icon
5
HCA Healthcare
HCA
$89.5B
$7M 2.03%
15,000
-2,000
-12% -$929K
TMO icon
6
Thermo Fisher Scientific
TMO
$220B
$6.95M 2.02%
12,000
-2,000
-14% -$1.13M
CAH icon
7
Cardinal Health
CAH
$55.4B
$6.68M 1.94%
32,500
-5,000
-13% -$941K
BSX icon
8
Boston Scientific
BSX
$71.5B
$6.67M 1.94%
70,000
– –
VRTX icon
9
Vertex Pharmaceuticals
VRTX
$126B
$6.24M 1.81%
13,770
-230
-2% -$99.1K
UHS icon
10
Universal Health Services
UHS
$10.5B
$6.11M 1.77%
28,000
– –
COR icon
11
Cencora
COR
$61.2B
$6.08M 1.76%
18,000
-2,000
-10% -$682K
ISRG icon
12
Intuitive Surgical
ISRG
$134B
$5.66M 1.64%
10,000
-3,000
-23% -$1.6M
EHC icon
13
Encompass Health
EHC
$12.4B
$5.31M 1.54%
50,000
+15,000
+43% +$1.74M
DHR icon
14
Danaher
DHR
$144B
$5.26M 1.53%
23,000
-12,000
-34% -$2.64M
ABT icon
15
Abbott
ABT
$187B
$5.01M 1.45%
40,000
+2,500
+7% +$318K
A icon
16
Agilent Technologies
A
$41.2B
$4.76M 1.38%
35,000
+2,000
+6% +$287K
ABBV icon
17
AbbVie
ABBV
$435B
$4.57M 1.33%
20,000
– –
SYK icon
18
Stryker
SYK
$130B
$4.57M 1.33%
13,000
– –
MDT icon
19
Medtronic
MDT
$112B
$4.32M 1.25%
45,000
-15,000
-25% -$1.46M
MTD icon
20
Mettler-Toledo International
MTD
$28.6B
$4.18M 1.21%
+3,000
New +$4.19M
SNN icon
21
Smith & Nephew
SNN
$12.6B
$4.1M 1.19%
125,000
-35,000
-22% -$1.2M
RGEN icon
22
Repligen
RGEN
$9.25B
$4.1M 1.19%
25,000
-2,500
-9% -$392K
UNH icon
23
UnitedHealth
UNH
$370B
$3.96M 1.15%
12,000
– –
BDX icon
24
Becton Dickinson
BDX
$48.2B
$3.88M 1.13%
+20,000
New +$3.81M
HUM icon
25
Humana
HUM
$46.2B
$3.84M 1.11%
15,000
-10,000
-40% -$2.62M
1
2

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
A
AFBI Miami Beach, Florida $131M AUM
SPWM
Schrum Private Wealth Management St. Augustine, Florida $131M AUM 18.38% 1-Year Est. Return

Sivik Global Healthcare's Q4 2025 Portfolio in Review

As of Q4 2025, Sivik Global Healthcare held 65 positions worth $345M, up 0.26% from $344M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Sivik Global Healthcare withdrew a net $15.5M in Q4 2025, closing 16 positions and reducing 14 holdings. Its most notable exit was Johnson & Johnson, an estimated $4.64M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 48% a quarter earlier.

Against the trend, Sivik Global Healthcare opened a new position in Mettler-Toledo International worth $4.18M.

  • Sivik Global Healthcare's largest Q4 2025 buy was Mettler-Toledo International: 3,000 shares worth $4.18M.
  • Sivik Global Healthcare added most to Encompass Health in Q4 2025, an estimated $1.74M increase.
  • Sivik Global Healthcare's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $2.87M.
  • Sivik Global Healthcare fully exited Johnson & Johnson in Q4 2025, selling an estimated $4.64M.
  • Sivik Global Healthcare's ten largest holdings make up 51% of its $345M portfolio in Q4 2025.
  • Sivik Global Healthcare opened 21 new positions and closed 16 in Q4 2025.
  • Sivik Global Healthcare's portfolio value rose 0.26% quarter-over-quarter to $345M.

Based on Sivik Global Healthcare's 13F filing for Q4 2025, filed 21 Jan 2026.